Xpress Biologics
Xpress Biologics

MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
BIOT
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬

Polyplus Boosts GMP Protein Production in Belgium
BIOT
🔍 Polyplus, part of Sartorius, expands GMP protein production and adds capacity in Belgium. Exciting news for Xpress Biologics! 🚀






